AiwuRuthHeMD

PubMed

• Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanc...
  Libbey, N., Gallagher, L., Rashid, A., Cantalino, J., Weinberg, B., Noel, M., He, A., Radkani, P., Marshall, J., Weiner, L., Jackson, P., Fishbein, T., Winslow, E., Ha...> ;Journal of Gastrointestinal Cancer. 2024 Feb 13
• Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma.
  Sadagopan, N., He, A.> ;International Journal of Molecular Sciences. 2024 Jan 19
• Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.
  Xiang, X., Bhowmick, K., Shetty, K., Ohshiro, K., Yang, X., Wong, L., Yu, H., Latham, P., Satapathy, S., Brennan, C., Dima, R., Chambwe, N., Sharifova, G., Cacaj, F., ...> ;Genes & Cancer. 2024 Jan 1
• Surgical resection criteria and neoadjuvant therapies for intrahepatic cholangiocarcinoma.
  James O'Bryan, Narayanan Sadagopan, Emily Winslow, Pejman Radkani, Thomas Fishbein, Filip Banovac, Emil Cohen, Marion L Hartley, Aiwu Ruth He> ;Clinical Advances in Hematology & Oncology. 2023 Nov 1
• 2 citations
  Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
  Do-Youn Oh, Aiwu Ruth He, Shukui Qin, Li-Tzong Chen, Takuji Okusaka, Arndt Vogel, Jin Won Kim, Thatthan Suksombooncharoen, Myung Ah Lee, Masayuki Kitano, Howard Burris...> ;Future Oncology. 2023 Nov 1
• Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC).
  Benjamin A Weinberg, Hongkun Wang, Marcus S Noel, Aiwu R He, John L Marshall, Louis M Weiner, Thomas M Fishbein, Nicole E Hodgins, Emily R Winslow, Patrick G Jackson, ...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Feb 1
• Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology.
  Philip Coffin, Aiwu He> ;International Journal of Molecular Sciences. 2023 Aug 26
• 3 citations
  Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.
  Anuradha Budhu, Erica C Pehrsson, Aiwu He, Lipika Goyal, Robin Kate Kelley, Hien Dang, Changqing Xie, Cecilia Monge, Mayank Tandon, Lichun Ma, Mahler Revsine, Laura Ku...> ;Cell Reports. Medicine. 2023 Jun 20
• 3 citations
  Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways andin Metastasis.
  Xiao, J., Jerry Xiao, Utsav Sharma, Abolfazl Arab, Sohit Miglani, Sonakshi Bhalla, Shravanthy Suguru, Robert Suter, Reetu Mukherji, Marc E Lippman, Paula R Pohlmann, J...> ;Cancers. 2023 Mar 17
• Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting.
  Abdalla Aly, Nicole Fulcher, Brian Seal, Trang Pham, Yunfei Wang, Scott Paulson, Aiwu R He> ;Hepatic Oncology. 2023 Mar 1
• 1 citations
  Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant.
  Chao Yin, Samantha Armstrong, Richard Shin, Xue Geng, Hongkun Wang, Rohit S Satoskar, Thomas Fishbein, Coleman Smith, Filip Banovac, Alexander Y Kim, Aiwu Ruth He> ;Annals of Gastroenterological Surgery. 2023 Mar 1
• Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.
  Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar, Hong Cao, Tetyana Duka, Bhaskar Kallakury, Sona Vasudevan, Jill P Smith> ;International Journal of Molecular Sciences. 2023 Feb 11
• 4 citations
  Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma.
  Stephanie M Woo, Alexandra V Kimchy, Lynette M Sequeira, Charles S Dorris, Aiwu R He, Amol S Rangnekar> ;Current Oncology. 2022 Dec 13
• 15 citations
  Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.
  Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B El-Khoueiry, Bruno Sa...> ;Journal of Clinical Oncology. 2023 Mar 20
• 32 citations
  Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
  Mark Yarchoan, Leslie Cope, Amanda N Ruggieri, Robert A Anders, Anne M Noonan, Laura W Goff, Lipika Goyal, Jill Lacy, Daneng Li, Anuj K Patel, Aiwu R He, Ghassan K Abo...> ;The Journal of Clinical Investigation. 2021 Dec 15
• 207 citations
  Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.
  Oh, D., Ruth He, A., Qin, S., Chen, L., Okusaka, T., Vogel, A., Kim, J., Suksombooncharoen, T., Ah Lee, M., Kitano, M., Burris, H., Bouattour, M., Tanasanvimon, S., Mc...> ;NEJM Evidence. 2022 Aug 1
• TKIs beyond immunotherapy predict improved survival in advanced HCC.
  Samantha Armstrong, Tina Roy, Bhavana Singh, Monika Kulasekaran, Fatima Shaukat, Xue Geng, Hongkun Wang, Petra Prins, Reena C Jha, Marion L Hartley, Aiwu Ruth He> ;Journal of Cancer Research and Clinical Oncology. 2023 Jun 1
• 164 citations
  Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma.
  Andrew X Zhu, Alexander R Abbas, Marina Ruiz de Galarreta, Yinghui Guan, Shan Lu, Hartmut Koeppen, Wenjun Zhang, Chih-Hung Hsu, Aiwu Ruth He, Baek-Yeol Ryoo, Thomas Ya...> ;Nature Medicine. 2022 Aug 1
• 2 citations
  The current state of molecular profiling in gastrointestinal malignancies.
  Reetu Mukherji, Chao Yin, Rumaisa Hameed, Ali Z Alqahtani, Monika Kulasekaran, Aiwu R He, Benjamin A Weinberg, John L Marshall, Marion L Hartley, Marcus S Noel> ;Biology Direct. 2022 Jun 6
• 2 citations
  Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?
  Chao Yin, Monika Kulasekaran, Tina Roy, Brennan Decker, Sonja Alexander, Mathew Margolis, Reena C Jha, Gary M Kupfer, Aiwu R He> ;Cancers. 2022 May 23
• 1 citations
  Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment.
  Christine C Hsu, Sunil Bansal, Hong Cao, Coleman I Smith, Aiwu Ruth He, Martha D Gay, Yaoxiang Li, Amrita Cheema, Jill P Smith> ;Pharmaceutics. 2022 Mar 12
• Pathogenesis to management of hepatocellular carcinoma.
  Ben L Da, Kelly I Suchman, Lawrence Lau, Atoosa Rabiee, Aiwu Ruth He, Kirti Shetty, Herbert Yu, Linda L Wong, Richard L Amdur, James M Crawford, Sharon S Fox, Gregory ...> ;Genes & Cancer. 2022 Jan 1
• 7 citations
  Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer.
  David S Hong, Ajay K Gopal, Alexander N Shoushtari, Sandip P Patel, Aiwu R He, Toshihiko Doi, Suresh S Ramalingam, Amita Patnaik, Shahneen Sandhu, Ying Chen, Craig B D...> ;Frontiers in Immunology. 2022 Jan 1
• 3 citations
  Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.
  Sobia Zaidi, Richard Amdur, Xiyan Xiang, Herbert Yu, Linda L Wong, Shuyun Rao, Aiwu R He, Karan Amin, Daewa Zaheer, Raj K Narayan, Sanjaya K Satapathy, Patricia S Lath...> ;Genes & Cancer. 2022 Jan 1
• 10 citations
  Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC.
  Leidy D Caraballo Galva, Xiaotao Jiang, Mohamed S Hussein, Huajun Zhang, Rui Mao, Pierce Brody, Yibing Peng, Aiwu Ruth He, Mercy Kehinde-Ige, Ramses Sadek, Xiangguo Qi...> ;Hepatology. 2022 Aug 1
• Join now to see all